Earnings Forecast of Novavax, Inc. (NVAX)

Jay Anderson
May 20, 2017

Several brokerages recently weighed in on NVAX. They now have a United States dollars 14 price target on the stock.

Price targets show what analysts believes a stock will be worth at the end of a certain time period. (NVAX) is its Earnings per Share or EPS. Piermont Capital Management Inc. increased its position in Novavax by 9.2% in the third quarter.

Novavax, Inc. (NVAX) stock price distance from twenty day simple moving average surged at 26.16% while its distance from fifty day simple moving average raised 3.57% along with -52.85% below distance from two hundred simple moving averages. Over the last three months, insiders have purchased 105,000 shares of company stock worth $90,800. JPMorgan Chase & Co. boosted its stake in Novavax by 110.5% in the third quarter. The average volume of a stock suggests the liquidity of a particular company. Shares of Novavax, Inc. The company's market cap is $269.45 Million, and the average volume is 6.56 Million. The stock appeared -87.87% below its 52-week highs and is up 24.10% for the last five trades.

Novavax, Inc. (NVAX)'s distance from 200 day simple moving average is -56.05 percent, its distance from 50 day simple moving average is -2.85 percent, while its distance from 20 day simple moving average is 20.61 percent. Novavax, Inc. (NVAX) 52 week low value is at $0.73 and its current distance from 52 week low value is 41.1%. Company shares were recently noted -34.88% off of the 50-day high and 12.00% away from the 50-day low.

Novavax Inc (NASDAQ:NVAX)'s revenue estimates for the current quarter are $5.7 Million according to 6 number of analysts, for the current quarter the company has high revenue estimates of $6.6 Million in contradiction of low revenue estimates of $4.5 Million. Sure, the percentage is discouraging but more headwinds are coming as looking out over a next 5-year period, analysts expect the company to see its earnings go down by 0%, annually. The firm's revenue for the quarter was down 7.7% compared to the same quarter previous year. Currently Novavax, Inc. (NVAX) has beta value of 2.09.

BC minority could have major implications for Alberta
The difference between the Liberals and NDP in the popular vote on Tuesday was about 17,800 votes in favour of Clark's party. In that riding, students picked city councillor and NDP candidate Anne Kang over Rick McGowan of the Green Party.

COPYRIGHT VIOLATION NOTICE: "State Board of Administration of Florida Retirement System Has $179,000 Position in Novavax, Inc".

NVAX has been the subject of several research analyst reports. Cantor Fitzgerald reaffirmed a "neutral" rating and issued a $2.00 target price on shares of Novavax in a report on Wednesday, March 1st. FBR & Co restated an "outperform" rating and set a $12.00 price objective on shares of Novavax in a research note on Wednesday, January 18th.

The stock increased +5.83% (+0.06) during the last days session, reaching 1.03 and roughly 4520269 shares were bought or sold by traders.

Some buy side analysts are also providing their Analysis on Novavax, Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 6 said it's a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. The stock witnessed -1.52% declines, -8.96% declines and -15.68% declines for the 1-month, 3-month and 6-month period, respectively. The earnings per share (EPS) term represents portion of a company's earnings with net of taxes as well as preferred stock dividends that is owed to each share of common stock. It has a Return on Investment (ROI) of 13.80% and a gross margin of 65.30%. Following the completion of the acquisition, the insider now directly owns 128,279 shares of the company's stock, valued at $107,754.36.

Other reports by BadHub

Discuss This Article

FOLLOW OUR NEWSPAPER